Development of Controlled-Release Matrix Tablet of Risperidone: Influence of Methocel®- and Ethocel®-Based Novel Polymeric Blend on In Vitro Drug Release and Bioavailability
- 15 April 2011
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 12 (2) , 525-533
Abstract
Controlled-release (CR) matrix tablet of 4 mg risperidone was developed using flow bound dry granulation–slugging method to improve its safety profile and compliance. Model formulations F1, F2, and F3, consisting of distinct blends of Methocel® K100 LV-CR and Ethocel® standard 7FP premium, were slugged. Each batch of granules (250–1,000 μm), obtained by crushing the slugs, was divided into three portions after lubrication and then compressed to 9-, 12-, and 15-kg hard tablets. In vitro drug release studies were carried out in 0.1 N HCl (pH 1.2) and phosphate buffer (pH 6.8) using a paddle dissolution apparatus run at 50 rpm. The CR test tablet, containing 30% Methocel® and 60% Ethocel® (F3) with 12-kg hardness, exhibited pH-independent zero-order release kinetics for 24 h. The drug release rate was inversely proportional to the content of Ethocel®, while the gel layer formed of Methocel® helped in maintaining the integrity of the matrix. Changes in the hardness of tablet did not affect the release kinetics. The tablets were reproducible and stable for 6 months at 40 ± 2°C/75 ± 5% relative humidity. Risperidone and its active metabolite, 9-hydroxyrisperidone, present in the pooled rabbit’s serum, were analyzed with HPLC-UV at λ max 280 nm. The CR test tablet exhibited bioequivalence to reference conventional tablet in addition to the significantly (p < 0.05) optimized peak concentration, C max, and extended peak time, T max, of the active moiety. There was a good association between drug absorption in vivo and drug release in vitro (R 2 = 0.7293). The successfully developed CR test tablet may be used for better therapeutic outcomes of risperidone.Keywords
This publication has 42 references indexed in Scilit:
- Controlled Release Matrix Tablets of Olanzapine: Influence of Polymers on the In Vitro Release and BioavailabilityAAPS PharmSciTech, 2010
- In Vitro Release Kinetics and Bioavailability of Gastroretentive Cinnarizine Hydrochloride TabletAAPS PharmSciTech, 2010
- Formulation and Evaluation of Gastroretentive Drug Delivery System of Propranolol HydrochlorideAAPS PharmSciTech, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing CarbamazepineAAPS PharmSciTech, 2008
- Development of a GC-MS Assay for the Determination of Fentanyl Pharmacokinetics in Rabbit Plasma after Sublingual Spray DeliveryThe AAPS Journal, 2008
- Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophreniaBMC Psychiatry, 2008
- Development and Evaluation of Buccoadhesive Controlled Release Tablets of LercanidipineAAPS PharmSciTech, 2008
- Controlled Release Matrix Tablets of Zidovudine: Effect of Formulation Variables on the In Vitro Drug Release KineticsAAPS PharmSciTech, 2008
- Design and study of lamivudine oral controlled release tabletsAAPS PharmSciTech, 2007